Vanderbilt and CDC Research Shows Third Vaccine Dose Key to

Vanderbilt and CDC Research Shows Third Vaccine Dose Key to Preventing Omicron Hospitalization

New research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant (65%) than previous variants, including alpha (85%) and delta (85%). However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.The almost year-long study, led by researchers at Vanderbilt University Medical Center, the Centers for Disease Control and Prevention (CDC) ...

Related Keywords

United States , Michigan , , Centers For Disease , Clinical Research Networks , Pfizer , Vanderbilt University Medical Center , University Of Michigan , Disease Control , Acutely Ill , Wesley Self , Emergency Medicine , Vice President , Cdc , Covid , Covid 19 , Dose , Health , Hospitalization , Lavergne , Murfreesboro , Nashville , News , Omicron , Preventing , Research , Rutherford County , Smyrna , Tennessee , Third , Tn , Vaccine , Vanderbilt ,

© 2025 Vimarsana